Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03614728
Title Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

chronic myelomonocytic leukemia

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Azacitidine + GSK3326595

GSK3326595

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.